Evidence for Load-Dependent and Load-Independent Determinants of Cardiac Natriuretic Peptide Production
- 1 June 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (11) , 2059-2067
Abstract
BackgroundIn hypertension with cardiac hypertrophy, the specific contributions to increased production of the cardiac natriuretic peptides (NP) atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) by load and the hypertrophic process are not known. In the present work we determine ANF and BNP synthesis and secretion in the aortic-banded rat treated with dosage schedules of the ACE inhibitor ramipril that result in the prevention or regression of both hypertension and hypertrophy (high dosage) or in the prevention or regression of hypertrophy alone with persistent hypertension (low dosage). Myosin heavy chain (MHC) isoform switch was studied as an indicator of ventricular cardiocyte hypertrophy as well as the levels of collagen III mRNA as a measure of changes in extracellular matrix.Methods and ResultsRamipril was administered for 6 weeks just after suprarenal aortic banding, or rats were banded for 6 weeks, after which ramipril was administered during the following 6 weeks. Banding caused an increase in blood pressure, left ventricular weight–to–body weight ratio, plasma and ventricular NP, ventricular NP mRNA, collagen III, and β-MHC mRNA. Ramipril at 1 mg/kg normalized all these parameters while ramipril at 10 μg/kg normalized left ventricular weight–to–body weight ratio but not blood pressure. Plasma and ventricular NP content and mRNA levels were partially normalized by ramipril (10 μg/kg). Ramipril (10 μg/kg) prevented increased collagen III mRNA levels but did not affect β-MHC mRNA levels.Conclusions(1) NP production and secretion in aortic-banded rats are independently related to increased blood pressure and hypertrophy. (2) A load-dependent component is more important than a load-independent component in regulating left ventricular NP production. (3) ANF production is more sensitive than BNP production to the load-independent component. (4) Low-dose ramipril treatment reverses hypertrophy and the increased collagen III expression but does not reverse the increased β-MHC isoform expression, suggesting that these are independently regulated processes. (5) Aortic banding and ACE inhibition do not affect atrial NP production and content.Keywords
This publication has 52 references indexed in Scilit:
- Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in RatsHypertension, 1995
- Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.Hypertension, 1994
- Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.Hypertension, 1994
- Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries.Hypertension, 1992
- Stretch-secretion coupling in atrial cardiocytes. Dissociation between atrial natriuretic factor release and mechanical activity.Hypertension, 1991
- Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats.Hypertension, 1991
- Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.Journal of Clinical Investigation, 1990
- Captopril and hydralazine suppress atrial natriuretic peptide (ANP) gene expression in the ventricles of spontaneously hypertensive ratBiochemical and Biophysical Research Communications, 1989
- Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR)Biochemical and Biophysical Research Communications, 1988
- The nucleotide sequence of a cDNA clone containing the entire coding region for mouse X-chromo- some-linked phosphoglycerate kinaseGene, 1986